2-232329847-G-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_152383.5(DIS3L2):​c.1774G>T​(p.Ala592Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,386,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A592V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000028 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000031 ( 0 hom. )

Consequence

DIS3L2
NM_152383.5 missense

Scores

1
3
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 7.86

Publications

1 publications found
Variant links:
Genes affected
DIS3L2 (HGNC:28648): (DIS3 like 3'-5' exoribonuclease 2) The protein encoded by this gene is similar in sequence to 3'/5' exonucleolytic subunits of the RNA exosome. The exosome is a large multimeric ribonucleotide complex responsible for degrading various RNA substrates. Several transcript variants, some protein-coding and some not, have been found for this gene. [provided by RefSeq, Mar 2012]
DIS3L2 Gene-Disease associations (from GenCC):
  • Perlman syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.039939433).
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0000279 (4/143274) while in subpopulation EAS AF = 0.000964 (4/4148). AF 95% confidence interval is 0.000329. There are 0 homozygotes in GnomAd4. There are 3 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152383.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DIS3L2
NM_152383.5
MANE Select
c.1774G>Tp.Ala592Ser
missense
Exon 15 of 21NP_689596.4
DIS3L2
NM_001257281.2
c.1582-13498G>T
intron
N/ANP_001244210.1
DIS3L2
NR_046476.2
n.1886-39G>T
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DIS3L2
ENST00000325385.12
TSL:5 MANE Select
c.1774G>Tp.Ala592Ser
missense
Exon 15 of 21ENSP00000315569.7
DIS3L2
ENST00000390005.9
TSL:1
n.1740-39G>T
intron
N/AENSP00000374655.5
DIS3L2
ENST00000445090.5
TSL:1
n.*966-36G>T
intron
N/AENSP00000388999.1

Frequencies

GnomAD3 genomes
AF:
0.0000279
AC:
4
AN:
143130
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000963
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000934
AC:
22
AN:
235632
AF XY:
0.0000622
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00124
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000177
GnomAD4 exome
AF:
0.0000314
AC:
39
AN:
1243004
Hom.:
0
Cov.:
36
AF XY:
0.0000244
AC XY:
15
AN XY:
615716
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
27006
American (AMR)
AF:
0.00
AC:
0
AN:
37236
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17938
East Asian (EAS)
AF:
0.00169
AC:
35
AN:
20656
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82680
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35300
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4560
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
971648
Other (OTH)
AF:
0.0000870
AC:
4
AN:
45980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000279
AC:
4
AN:
143274
Hom.:
0
Cov.:
32
AF XY:
0.0000430
AC XY:
3
AN XY:
69694
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
39850
American (AMR)
AF:
0.00
AC:
0
AN:
14508
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3340
East Asian (EAS)
AF:
0.000964
AC:
4
AN:
4148
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3898
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9198
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
286
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
65134
Other (OTH)
AF:
0.00
AC:
0
AN:
2038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000491
ExAC
AF:
0.0000745
AC:
9

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Perlman syndrome Uncertain:2
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 592 of the DIS3L2 protein (p.Ala592Ser). This variant is present in population databases (rs183714146, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with DIS3L2-related conditions. ClinVar contains an entry for this variant (Variation ID: 410766). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt DIS3L2 protein function with a negative predictive value of 80%. RNA analysis performed to evaluate the impact of this missense change on mRNA splicing indicates it does not significantly alter splicing (internal data). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.27
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.047
T
Eigen
Benign
-0.047
Eigen_PC
Benign
0.16
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.93
D
M_CAP
Benign
0.028
D
MetaRNN
Benign
0.040
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.65
N
PhyloP100
7.9
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.18
Sift
Benign
0.035
D
Sift4G
Benign
0.34
T
Polyphen
0.041
B
Vest4
0.76
MVP
0.093
MPC
0.75
ClinPred
0.12
T
GERP RS
5.3
Varity_R
0.32
gMVP
0.46
Mutation Taster
=67/33
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183714146; hg19: chr2-233194557; API